Literature DB >> 20536500

Improvements in glycaemic control and cholesterol concentrations associated with the Quality and Outcomes Framework: a regional 2-year audit of diabetes care in the UK.

I Oluwatowoju1, E Abu, S H Wild, C D Byrne.   

Abstract

AIMS: To determine whether there have been changes in glycaemic control and lipids in a cohort of people with repeated glycated haemoglobin (HbA(1c)) measurements since the implementation of the Quality and Outcomes Framework (QOF) for diabetes care.
METHODS: Retrospective retrieval of computer-held biochemical measurements of glycaemic control (HbA(1c)) and lipid profiles in adults in Hampshire, UK between 2006 and 2008. Routine data on age, sex, HbA(1c) and plasma lipids were available on an NHS database on 8997 adults with data available for HbA(1c) in both 2006 and 2008.
RESULTS: In 2006, 39.7% of adults had glycaemic control within the QOF threshold (HbA(1c) < 7.5%); by 2008, this proportion had risen to 52.1% (P < 0.001). In 2006, 11.8% of subjects had poor glycaemic control (HbA(1c) > 10.0%); by 2008, this proportion had decreased to 10.1% (P < 0.001). The proportion of subjects achieving HbA(1c) and cholesterol targets (both HbA(1c) < 7.5% and total cholesterol < or = 5.0 mmol/l) was 30.2% in 2006; in 2008, this proportion had increased to 43.7% (P < 0.001). Individuals with poorer glycaemic control (HbA(1c) > 10.0%) were younger and had higher cholesterol concentrations than people with good (HbA(1c) < 7.5%) or moderate (HbA(1c) 7.5-10.0%) glycaemic control (P value for trend, both P < 0.001).
CONCLUSION: Since the introduction of performance indicators for primary care and the incorporation of pay for performance in 2004, there has been marked improvement in the management of hyperglycaemia and hypercholesterolaemia among people with diabetes with data available in 2006 and 2008. It remains to be seen whether the new HbA(1c) audit target (HbA(1c) < 7.0%) introduced in 2009 will result in a further improvement in glycaemic control.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536500     DOI: 10.1111/j.1464-5491.2010.02951.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  14 in total

1.  Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).

Authors:  H Yokoyama; S Araki; M Haneda; M Matsushima; K Kawai; K Hirao; M Oishi; K Sugimoto; H Sone; H Maegawa; A Kashiwagi
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

2.  Ethnic and social disparity in glycaemic control in type 2 diabetes; cohort study in general practice 2004-9.

Authors:  Gareth D James; Peter Baker; Ellena Badrick; Rohini Mathur; Sally Hull; John Robson
Journal:  J R Soc Med       Date:  2012-03-06       Impact factor: 5.344

3.  Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers.

Authors:  L Ranganath; A M Taylor; A Shenkin; W D Fraser; J Jarvis; J A Gallagher; N Sireau
Journal:  J Inherit Metab Dis       Date:  2011-02-11       Impact factor: 4.982

4.  "This does my head in". Ethnographic study of self-management by people with diabetes.

Authors:  Susan Hinder; Trisha Greenhalgh
Journal:  BMC Health Serv Res       Date:  2012-03-29       Impact factor: 2.655

5.  Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?

Authors:  Elise Chia-Hui Tan; Raoh-Fang Pwu; Duan-Rung Chen; Ming-Chin Yang
Journal:  Qual Life Res       Date:  2013-08-23       Impact factor: 4.147

6.  Diabetes performance measures: current status and future directions.

Authors:  Patrick J O'Connor; Noni L Bodkin; Judith Fradkin; Russell E Glasgow; Sheldon Greenfield; Edward Gregg; Eve A Kerr; L Gregory Pawlson; Joseph V Selby; John E Sutherland; Michael L Taylor; Carol H Wysham
Journal:  Diabetes Care       Date:  2011-07       Impact factor: 19.112

7.  Type 2 diabetes: a cohort study of treatment, ethnic and social group influences on glycated haemoglobin.

Authors:  Gareth D James; Peter Baker; Ellena Badrick; Rohini Mathur; Sally Hull; John Robson
Journal:  BMJ Open       Date:  2012-10-18       Impact factor: 2.692

8.  Combining QOF data with the care bundle approach may provide a more meaningful measure of quality in general practice.

Authors:  Carl de Wet; John McKay; Paul Bowie
Journal:  BMC Health Serv Res       Date:  2012-10-08       Impact factor: 2.655

Review 9.  The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years.

Authors:  Alberto Martínez-Castelao; Juan F Navarro-González; José Luis Górriz; Fernando de Alvaro
Journal:  J Clin Med       Date:  2015-05-28       Impact factor: 4.241

10.  A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010.

Authors:  Gerald Liew; Michel Michaelides; Catey Bunce
Journal:  BMJ Open       Date:  2014-02-12       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.